Showing 8511-8520 of 20878 results for "".
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
https://reachmd.com/programs/project-oncology/io-therapies-for-patients-with-her2-negative-ggejc/35513/For patients who are diagnosed with metastatic gastric cancer, the five-year overall survival rate is roughly seven percent, underscoring the need for additional treatment options.1 Fortunately, there has been advancement in gastric cancer care, including the FDA approval of tislelizumab plus platinScreening and Prophylaxis for Venous Thromboembolism
https://reachmd.com/programs/advances-in-long-term-care-medicine/screening-and-prophylaxis-for-venous-thromboembolism/5825/Patients who have recently had orthopedic and other types of general surgery, those who have recently had a stroke, and those with an ongoing medical condition (such as heart disease) are at most risk for developing venous thromboembolic disease. Do most long-term care facilities screen for this conNatural History of Breast Cancer: Early Detection vs. Mortality
https://reachmd.com/programs/focus-on-cancer/natural-history-of-breast-cancer-early-detection-vs-mortality/4319/The widespread use of mammography to screen for breast cancer has resulted in a decrease in breast tumor detection, as well as decrease in mortality rates associated with the disease. But the natural course of malignant diseases such as different types of cancer can vary considerably. Is it possibleDr. Dean Ornish, President of the Preventive Medicine Research Institute
https://reachmd.com/programs/conversations-on-health-care/dr-dean-ornish-president-preventive-medicine-research-institute/7939/This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Dean Ornish, Founder and President of the Preventive Medicine Research Institute. He analyzes the new USDA nutritional guidelines and discusses the mounting empirical evidence linking sound nutrition and integrative medicine to the pEpilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://reachmd.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.Selecting the Right Neuromodulator
https://reachmd.com/ma-issues-index/march-april-2026-issue/selecting-the-right-neuromodulator/56635/Subtle differences in botulinum toxin formulations and technique shape individualized aesthetic outcomesAesthetic Laser Innovators Discuss What Is Next
https://reachmd.com/programs/modern-aesthetics-focus-on-energy-based-devices/aesthetic-laser-innovators-discuss-what-is-next/56627/A roundtable discussion with Jill S. Waibel, MD, FACS, FAAD; R. Rox Anderson, MD, FAAD; Roy Geronemus, MD; and E. Victor Ross, MD, FAADA Resurgence of Stents
https://reachmd.com/programs/diabetes-discourse/a-resurgence-of-stents/4693/Diabetes is strongly linked with a number of risk factors for coronary problems such as high blood pressure, high cholesterol, abdominal obesity that significantly increases the risk of heart attack and stroke. Recent studies indicate that new drug-eluting stents are a reasonable option for the diabAPRIL Uncovered: An Upstream Driver in IgAN
https://reachmd.com/programs/cme/april-uncovered-an-upstream-driver-in-igan/54680/Drs. Lafayette, Risk, Suzuki, and Zhang discuss how APRIL fits into the 4-hit hypothesis of IgAN pathogenesis and review emerging disease-modifying therapies.IgAN SOC: Strengths and Limits
https://reachmd.com/programs/cme/igan-soc-strengths-and-limits/54682/Drs. Lafayette, Risk, Suzuki, and Zhang discuss how APRIL fits into the 4-hit hypothesis of IgAN pathogenesis and review emerging disease-modifying therapies.